- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | B.Riley initiates Prenetics stock coverage with buy rating on IM8 growth | 4 | Investing.com | ||
| Do | B.Riley stuft Prenetics Aktie mit "Buy" ein - Wachstum durch IM8 im Fokus | 1 | Investing.com Deutsch | ||
| Mi | Prenetics Global CEO and CFO purchase $1M of shares in open market | 2 | Seeking Alpha | ||
| Mi | Prenetics Global Limited: Prenetics' IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results | 2 | GlobeNewswire (USA) | ||
| Mi | Prenetics Global Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 21.08. | Prenetics Global Ltd - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 20.08. | Prenetics Global Limited: Prenetics' IM8 Announces Two-Time Golden Globe-Nominated Actress and Producer Lily Collins as IM8 Global Ambassador and Shareholder in Multi-Year Partnership | 1 | GlobeNewswire (USA) | ||
| 18.08. | Prenetics Q2 2026 slides: cash flow turns positive, $1B deal fuels growth | 10 | Investing.com | ||
| PRENETICS GLOBAL Aktie jetzt für 0€ handeln | |||||
| 18.08. | Prenetics Global GAAP EPS of -$0.53 beats by $0.01, revenue of $46.5M misses by $2.68M | 2 | Seeking Alpha | ||
| 18.08. | Prenetics Global Limited: Prenetics' IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220-230 Million | 546 | GlobeNewswire (Europe) | Total revenue of $46.5 million, up ~288% YoY (~3.9x); within the Company's guidance of $46-48 millionIM8 revenue of $45.0 million, up ~359% YoY (~4.6x); within the Company's guidance of $44-46 million... ► Artikel lesen | |
| 17.08. | Prenetics Global Q2 2026 Earnings Preview | 5 | Seeking Alpha | ||
| 17.08. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.08. | Prenetics Global Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 07.08. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 15.07. | Prenetics Raises $1 Billion For IM8 Via General Catalyst's Customer Value Fund | 3 | pulse2.com | ||
| 14.07. | Prenetics Global Limited: Prenetics' IM8 Secures $1 Billion Growth Financing from General Catalyst's Customer Value Fund (CVF) | 4 | GlobeNewswire (USA) | ||
| 14.07. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 25.06. | Prenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market Growth | 1 | Insider Monkey | ||
| 10.06. | Prenetics posts revenue growth, lifts 2026 outlook | 14 | Seeking Alpha | ||
| 10.06. | Prenetics raises 2026 IM8 revenue guidance on strong growth | 4 | Investing.com |
1 2 3 Weiter >>
54 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | 682,40 | -0,41 % | Veeva Systems: Veeva Vault CRM Selected by Regeneron | Leading biopharma company selects agentic CRM for life sciences to generate Commercial EvidencePLEASANTON, Calif., Aug. 25, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced... ► Artikel lesen | |
| VIKING THERAPEUTICS | 27,850 | +0,36 % | Viking Therapeutics Has $502 Million in Cash and 1 Big Catalyst Left in 2026 -- Is That Enough? | ||
| CANSINO BIOLOGICS | 3,460 | -1,70 % | CanSino Biologics Inc: Overseas Growth Gathers Momentum as CanSinoBIO's Global Strategy Unlocks New Opportunities | HONG KONG, Aug 27, 2026 - (ACN Newswire) - CanSino Biologics Inc. ('CanSinoBIO,' 06185.HK/688185.SH) released its financial results for the first half of 2026. The Company reported revenue of approximately... ► Artikel lesen | |
| GUARDANT HEALTH | 138,50 | -0,69 % | Final judgement favours TwinStrand in Guardant patent case | ||
| SINO BIOPHARM | 0,619 | +0,44 % | SBP GROUP (01177): VOLUNTARY ANNOUNCEMENT - APPLICATION FOR CLINICAL TRIAL ON LM-364 "NECTIN-4 TME ADC" APPROVED BY NMPA AND FDA | ||
| BIO-TECHNE | 62,54 | +0,13 % | Dividendenbekanntmachungen (24.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3M COMPANY US88579Y1010 0,78 USD 0,668 EUR ABN AMRO BANK NV ADR US00080Q1058 0,7837 USD 0,6711 EUR ABRDN AUSTRALIA EQUITY FUND... ► Artikel lesen | |
| INNOVENT BIOLOGICS | 11,640 | -1,56 % | Innovent Biologics: Innovent Announces 2026 Interim Results and Business Updates | Transforming from Regional Leader to Global Premier:
A Clear Strategic Path for Growth and Globalization
SAN FRANCISCO and SUZHOU, China, Aug. 25, 2026 /PRNewswire/... ► Artikel lesen | |
| GENSCRIPT BIOTECH | 3,800 | -1,04 % | HSI Closes at 25,652, Up 141 pts; HSTI Closes at 4,626, Up 37 pts; INNOVENT BIO Up over 9%; INNOVENT BIO, H&H INTL HLDG, GENSCRIPT BIO Hit New Highs; Market Turnover Rises | ||
| QUANTUM-SI | 0,780 | +0,01 % | Quantum-Si Incorporated: Quantum-Si Announces the Start of the Proteus Roadshow | Multi-city Roadshow To Drive Awareness of Proteus and Develop Customer Funnel for Commercial Launch Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics... ► Artikel lesen | |
| AKESO | 10,460 | +0,87 % | Akeso, Inc.: Akeso 2026 Interim Results: Strong Commercialization Momentum; IO2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's | HONG KONG, Aug. 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2026 interim results. During the reporting period, the Company... ► Artikel lesen | |
| SCILEX | 4,960 | +4,64 % | Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens Commence Trading on the Biconomy Exchange on July 6, 2026 | PALO ALTO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and... ► Artikel lesen | |
| ORIGIN AGRITECH | 0,850 | 0,00 % | Origin Agritech Limited: Origin Agritech Announces Financial Results for the First Half of Fiscal Year 2026 | Net Loss Narrows by 44% Year-Over-Year, Driven by 44% Reduction in Operating Expenses
BEIJING, May 21, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED)... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 39,210 | 0,00 % | Wolfe Research initiates Harmony Biosciences stock at Outperform | ||
| NIKI BIOSOLUTIONS | 6,990 | -2,78 % | Aptorum Group Ltd: Aptorum Group Provides Update on DiamiR Biosciences Merger / Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker "NIKI" | Aptorum Group Announces 1-for-10 Reverse Share Split and Delaware Redomestication in Connection with the Merger The Merger is Expected to Close in July 2026 NEW YORK, NY, July 16, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 13,730 | 0,00 % | Summit Therapeutics Partner Highlights Positive Interim Data Milestone for Lead Cancer Therapy |
PRENETICS GLOBAL LIMITED gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von +0,100 (+0,39 %) liegt der Kurs bei 25,860 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PRENETICS GLOBAL LIMITED finden Sie auf Wallstreet Online.